Neda Nilforoushan

Dr. Neda Nilforoushan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
NMNarjes Mohammadzadeh
Narjes Mohammadzadeh
KVKiana Tadbir Vajargah
Kiana Tadbir Vajargah
Neda NilforoushanNeda Nilforoushan
Neda Nilforoushan
MAMohammad Ashouri
Mohammad Ashouri
AJAli Jafarian
Ali Jafarian
SESeyed Hassan Emami-Razavi
Seyed Hassan Emami-Razavi
Background: Since the emergence of the COVID-19 pandemic, medical education has been a concerning issue, especially in surgical fields. Due to the postponement of many elective surgeries and even alternations in the pattern of emergent surgeries, concerns have been raised about whether residents of surgical disciplines are experienced enough after graduation or not. We aimed to describe the impact of the COVID-19 pandemic on surgical residency training in different fields. Materials and methods: We conducted a cross-sectional study with a 20-item questionnaire on residents of surgical disciplines from three different educational hospitals of Tehran University of Medical Sciences, Iran in 2020. In addition, we reviewed the current literature regarding the impact of COVID-19 pandemic on surgical education worldwide. Results: Our survey, with a response rate of 56.8% demonstrated significant reduction in the time spent in elective surgeries, surgical clinics and even in emergent surgeries for residents. Besides, it has reported that significant time has been spent in COVID 19 wards which resulted in decreased satisfaction of educational activities. Conclusions: The impacts of COVID 19 pandemic on surgical education are significant and inevitable. Thus, we must integrate novel educational methods in surgical curriculum to optimize training and minimize the adverse effects of the pandemic on surgical education.

17 December 2025 in Tomography
Verified
Journal Article
Open access
PDF file
Neda NilforoushanNeda Nilforoushan
Neda Nilforoushan
AKAshkan Khavaran
Ashkan Khavaran
MPMaierdan Palihati
Maierdan Palihati
YPYashvi Patel
Yashvi Patel
AGAnna O. Giarratana
Anna O. Giarratana
KCKathleen Capaccione
Kathleen Capaccione
Cancer-associated fibroblasts (CAFs) are an abundant and diverse cell population within tumor microenvironments of solid tumors. Multiple subtypes of CAFs, defined by molecular and functional markers, have been described in the literature. CAFs contribute to tumor progression by remodeling the extracellular matrix, promoting immune evasion, and supporting angiogenesis and metastasis. Fibroblast activation protein (FAP) is a transmembrane serine protease minimally expressed in normal adult tissues but significantly upregulated in certain subtypes of CAFs across many solid tumors. High levels of FAP have been associated with poor prognosis in various cancers. FAP has increasingly emerged as a promising target for both imaging and therapy. Multiple FAP-targeting strategies, such as small molecules, monoclonal antibodies, drug conjugates, and radiolabeled ligands, are currently being investigated in preclinical and early clinical settings. This review provides a clinically focused overview of CAFs in the tumor microenvironment, highlighting key fibroblast markers, their associations with prognosis across various tumor types, and their utility in radiologic imaging and targeted therapy. We also discuss the potential of non-FAP fibroblast targeting molecules and the clinical rationale for more selective, subtype-specific strategies. By examining fibroblast biology through a radiologist’s lens, we aim to explore the evolving role of stromal targeting in imaging and the treatment of solid tumors.

13 July 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
NMNarjes Mohammadzadeh
Narjes Mohammadzadeh
Neda NilforoushanNeda Nilforoushan
Neda Nilforoushan
MAMohammad Ashouri
Mohammad Ashouri
Introduction & importance: Gastrointestinal tract is an uncommon site for primary melanoma and its annual incidence is reported 0.47 cases in million. Thus, limited information is available about its medical or surgical treatment, long-term complications of melanoma, and survival rates of each therapeutic method. Case presentation: A 47-year-old male was admitted to the emergency department with massive rectorrhagia. with not notable medical history except recent episodes of dyspepsia, melena, malaise and weight loss. Melena and weight loss in a 47-year-old patient is considered as suspicious signs for malignancy and should be investigated. The patient was finally diagnosed with primary gastrointestinal melanoma (PGIM). He underwent trans-hiatal total esophagectomy and proximal gastrectomy with gastric pull-up and lymph node dissection. Immunotherapy with Interferon-alpha was chosen as adjuvant therapy for this patient. After 10 months, CT scan of abdomen with intravenous and oral contrast revealed multiple foci in liver and spleen consistent with metastasis without any evidence of recurrence at primary tumor excision site. Clinical discussion: In this article, we presented a rare case of PGIM with later metastasis in liver and spleen. Gastric pull up was preferred to colon interposition for conduit reconstruction after esophagectomy in this case. However due to the rarity of this category of tumor more information must be gathered on the amount of margin to be resected and long-term outcome of different surgical approaches. Conclusion: Based on the poor prognosis of PGIM, less invasive surgical procedure which provides the radical resection and adequate onco-surgical dissection should be considered.